Open an account

Universe Pharmaceuticals

UPC · NASDAQ

$4.04+$0.489 (+13.77%)TodayMarket open · · Delayed 15 min
Prev close $3.55

About UPC

Universe Pharmaceuticals, Inc. is a pharmaceutical company. The company is headquartered in Ji'An, Jiangxi and currently employs 216 full-time employees. The company went IPO on 2021-03-23. The Company’s products include chronic condition treatments and cold and flu medicines. The chronic condition treatments primarily include Guben Yanling Pill, Shenrong Weisheng Pill, Quanlu Pill, Yangxue Danggui Syrup, Wuzi Yanzong Oral Liquid, Fengtong Medicinal Liquor, Shenrong Medicinal Liquor, Qishe Medicinal Liquor, Fengshitong Medicinal Liquor, and Shiquan Dabu Medicinal Liquor. The cold and flu medicines primarily include Paracetamol Granule for children, Isatis Root Granule and Qiangli Pipa Syrup. The firm is also engaged in the sales of biomedical drugs medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies.

Employees
225
Headquarters
Ji'an, Jiangxi
Listed
Mar 23, 2021
Sector
Health Care
Industry
Pharmaceuticals
Website
universe-pharmacy.com

UPC key statistics

Market cap
17.84M
Price-earnings ratio
—
Dividend yield
—
Average volume
13.58K
Volume
62.15K
Open price
$3.59
High today
$4.28
Low today
$3.54
52 Week high
$17.96
52 Week low
$2.00

Universe Pharmaceuticals (UPC) at a glance

As of Oct 21, 2026, Universe Pharmaceuticals (UPC) shares are priced at $4.04, giving the company a market cap of 17.84M.

Today the stock has traded between $3.54 and $4.28. The current price is 14.1% above the day's low and 5.6% below its high.

Volume so far is 62.15K shares, above the average of 13.58K shares a day.

Over the past year Universe Pharmaceuticals has ranged from $2.00 to $17.96, and now sits 13% of the way up that range.

UPC news

  • Press releaseBusiness Wire

    Law Offices of Howard G. Smith Announces Investigation of Universe Pharmaceuticals INC. (UPC) on Behalf of Investors

  • Press releaseBusiness Wire

    The Law Offices of Frank R. Cruz Announces Investigation of Universe Pharmaceuticals INC. (UPC) on Behalf of Investors

  • Rishabh Mishra

    Stock Market Today: Dow Jones, S&P 500 Futures Rise, Nasdaq 100 Falls as US-Iran Tensions Escalate— DELL, PANW, MDB, AVGO in Focus (UPDATED)

  • Mohd Haider

    Universe Pharmaceuticals (UPC) Stock Soars Over 38% After-Hours: Here's What's Going On

  • 12 Health Care Stocks Moving In Monday's Pre-Market Session

  • 12 Health Care Stocks Moving In Thursday's After-Market Session

  • Avi Kapoor

    Crude Oil Gains 2%; Comcast Shares Spike Higher

  • Press releaseGlobe Newswire

    4 Sizzling Biotech and Healthcare Companies Reporting Strategic Milestones

Similar companies

Companies in the same industry as Universe Pharmaceuticals

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.